Related Experiment Videos
Growth of hyperactive children treated with methylphenidate
Archives of General Psychiatry
|February 1, 1979
Summary
Methylphenidate hydrochloride may temporarily impact height and weight in hyperactive boys during the first year of treatment. However, these effects are minor and typically offset by the second year, showing little clinical significance.
Area of Science:
- Pediatric endocrinology
- Child psychology
- Pharmacology
Background:
- Methylphenidate hydrochloride is a common treatment for attention deficit hyperactivity disorder (ADHD).
- Concerns exist regarding its potential impact on growth in children.
- Long-term growth effects require further investigation.
Purpose of the Study:
- To assess the longitudinal effects of methylphenidate hydrochloride on the growth of hyperactive boys.
- To identify potential predictors of growth deficits.
- To determine the clinical significance of observed growth changes.
Main Methods:
- A cohort of 72 hyperactive boys received continuous methylphenidate hydrochloride treatment.
- Growth in height and weight was monitored over two years.
- Data analysis explored correlations between growth, dosage, and side effects.
Main Results:
- A temporary adverse effect on height and weight was observed in the first year of treatment.
- This deficit was compensated by accelerated growth in the second year.
- No clinical predictors for height deficits were identified; weight deficits may relate to dosage or drug holidays.
- Side effects did not correlate with dosage.
Conclusions:
- Methylphenidate hydrochloride's impact on growth is temporary and clinically insignificant.
- The drug does not appear to cause long-term growth impairment in hyperactive boys.
- Further research may explore weight-related factors more closely.